Human pancreatitis and the role of cathepsin B

Gut

Volumn 55, Issue 9, 2006, Pages 1228-1230

  Lerch, M M ^a   Halangk, W ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; ENZYME PRECURSOR; LYSOSOME ENZYME; PANCREAS ENZYME; PROTEINASE; TRYPSIN; TRYPSINOGEN;

ACINAR CELL; ACUTE PANCREATITIS; CYTOPLASM VESICLE; DIGESTION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SYNTHESIS; GENE; GENE DELETION; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; IMMUNOGOLD ELECTRON MICROSCOPY; IN VITRO STUDY; LYSOSOME; NOTE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINK1 GENE;

ACUTE DISEASE; CATHEPSIN B; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PANCREATITIS; POLYMORPHISM, GENETIC;

EID: 33747766204     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.092114     Document Type: Note

References (29)

1. Chiari H. Über die Selbstverdauung des menschlichen Pankreas. Z Heilk 1896;17:69-96.
2. Halangk W, Krüger B, Ruthenbürger M, et al. The role or trypsin in premature, intrapancreatic trypsinogen activation and inactivation of trypsin activity. Am J Physiol Gastrointest Liver Physiol 2002;282:G367-74.
3. Kruger B, Albrecht E, Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol 2000;157:43-50.
4. Lerch MM, Saluja AK, Dawra R, et al. Acute necrotising pancreatitis in the opossum: earliest morphologic changes involve acinar cells. Gastroenterology 1992;103:205-13.
5. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
6. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.
7. Hofbauer B, Saluja AK, Lerch MM, et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Phys 1998;275:G352-62.
8. Otani T, Chepilko SM, Grendell JH, et al. Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol 1998;275:G999-1009.
9. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med 1987;316:144-50.
10. Figarella C, Miszczuk-Jamska B, Barrett A. Possible lysosomal activation of pancreatic zymogens: activation of both human trypsinogens by cathepsin B and spontaneous acid activiation or human trypsinogen-1. Biol Chem Hoppe-Seyler 1988;369:293-8.
11. Saluja A, Sadamitsu H, Saluja M, et al. Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. Am J Physiol 1987;253:G508-16.
12. Watanabe O, Baccino FM, Steer ML, et al. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 1984;246:G457-67.
13. Leach SD, Modlin IM, Scheele GA, et al. Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high does of cholecystokinin. J Clin Invest 1991;87:362-6.
14. Saluja AK, Donovan EA, Yamanaka K, et al. Cerulein-induced in vitro activation of trypsinogen inrat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-10.
15. Steer ML, Saluja AK. Experimental acute pancreatitis: studies of the early events that lead to cell injury. In: Go VLW, DiMagno EP, Gardner JD, et al. The pancreas: biology, pathobiology, and disease. New York: Raven Press, 1993:489-500.
16. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-81.
17. Szilagyi L, Kenesi E, Katona G, et al. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 2001;276:24574-80.
18. Simon P, Weiss FU, Sahin-Tóth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002;277:5404-10.
19. Kukor Z, Mayerle J, Kruger B, et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 2002;277:21389-96.
20. Tooze J, Hollinshead M, Hensel G, et al. Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol 1991;56:187-200.
21. Mahurkar S, Idris MM, Reddy DN, et al. Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut 2006;55:1270-5.
22. Chandak GR, Idris MM, Reddy DN, et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PST1/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002;39:347-51.
23. Chandak GR, Idris MM, Reddy DN, et al. Absence of PRSS1 mutations and association of SRNK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 2004;53:723-8.
24. Kuwata K, Hirota M, Shimizu H, et al. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 2002;37:928-34.
25. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-16.
26. Weiss FU, Simon P, Bogdanova N, et al. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 2005;54:1456-60.
27. Weiss FU, Simon P, Witt H, et al. SPINK1 mutations and phenotype expression in patients with trypsinogen mutation-associated pancreatitis. J Med Genet 2003;40:1-5.
28. Szmola R, Kukor Z, Sahin-Toth M. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J Biol Chem 2003;278:48580-9.
29. Ohmuraya M, Hirota M, Araki M, et al. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-defictent mice. Gastroenterology 2005;129:696-705.